Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of K-877 CR vs IR in Healthy Volunteers
NCT03702673Phase 1Completed
- Start
- Oct 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pemafibrate in hypertriglyceridemia and dyslipidemia (4 arms). Primary endpoints: Area Under the Plasma Concentration Versus Time Curve at 24 hours and Maximum Measured Plasma Concentration at 24 hours. Started Oct 2018; status: completed.
02
Drugs
pemafibrate
03
Conditions
hypertriglyceridemiadyslipidemia
Beyond the preview
Go deeper on NCT03702673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03702673.